Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Dissociative symptoms are common, possibly severe, side effects associated with the use of ketamine and esketamine in depression. We investigated the relationship between trait dissociation and dissociation induced by ketamine and esketamine used as augmentation therapy in treatment-resistant depression (TRD). Adults with TRD were randomly assigned to receive a single intravenous infusion, with a duration of 40 min, of either esketamine 0.25 mg/kg or ketamine 0.5 mg/kg. We assessed trait dissociation with the Dissociative Experience Scale (DES) and, to evaluate induced dissociation, the Clinician-Administered Dissociative States Scale (CADSS) was used. Thirty-two subjects received esketamine and 29 received ketamine. The groups had similar median DES scores (p = 0.26). More than 30% of the patients in both groups had DES scores ≥30 points. The median CADSS score in the esketamine group was equivalent to that in the ketamine group (p = 0.40). Every 5 points increment in the DES was associated with a 10.9% (95% CI 4.5-17.8%) increase in the CADSS, in an exponential fashion when the two groups were pooled together. Subjects with high trait dissociation had a higher risk of induced dissociation state (relative risk [RR] 1.41, 95% CI 1.11-1.78) and very high induced dissociation (RR 3.05, 95% CI 1.14-8.15). Induced dissociation was not a serious adverse effect. The findings suggest that trait dissociation is a predictor of induced dissociation by Ketamine or Esketamine in TRD subjects. Screening for trait dissociation and counseling patients with high trait dissociation on the risks of dissociation by these drugs are recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030392 · Cited by 1,205
Diazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963
Popova, V., Daly, E. J., Trivedi, M., Cooper, K., Lane, R., Lim, P., Mazzucco, C., Hough, D., Thase, M. E., Shelton, R. C., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19020172 · Cited by 904
Types of dissociation and dissociative types: A taxometric analysis of dissociative experiences.
Waller, N., Putnam, F. W., & Carlson, E. B. (1996) · Psychological Methods · doi:10.1037/1082-989x.1.3.300 · Cited by 894
Bremner, J. D., Krystal, J. H., Putnam, F. W., Southwick, S. M., Marmar, C., Charney, D. S., & Mazure, C. M. (1998) · Journal of Traumatic Stress · doi:10.1023/a:1024465317902 · Cited by 817
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
Yang, C., Shirayama, Y., Zhang, J.-C., Ren, Q., Yao, W., Ma, M., Dong, C., & Hashimoto, K. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.136 · Cited by 605
Side-effects associated with ketamine use in depression: a systematic review
Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30272-9 · Cited by 558
Lyssenko, L., Schmahl, C., Bockhacker, L., Vonderlin, R., Bohus, M., & Kleindienst, N. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17010025 · Cited by 541
Fava, M., Freeman, M. P., Flynn, M., Judge, H., Hoeppner, B. B., Cusin, C., Ionescu, D. F., Mathew, S. J., Chang, L. C., Iosifescu, D. V., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0256-5 · Cited by 433
Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
Kim, J., Farchione, T., Potter, A., Chen, Q., & Temple, R. (2019) · New England Journal of Medicine · doi:10.1056/nejmp1903305 · Cited by 333
Research works printed but not linked: 36
- Acevedo-Diaz, 2020, Can ‘floating’ predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression, J. Psychiatr. Res., 130, 280, 10.1016/j.jpsychires.2020.06.012 · DOI
- Administration, 2019, Psychopharmacologic drugs advisory committee (PDAC) and drug safety and risk management (DSaRM) advisory committee meeting, Advis. Comm. Meet. 2019
- Ajub, 2018, Efficacy of esketamine in the treatment of depression with psychotic features: a case series, Biol. Psychiatr., 83, e15, 10.1016/j.biopsych.2017.06.011 · DOI
- Amorim, 2000, Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais, Rev. Bras. Psiquiatr., 22, 106, 10.1590/S1516-44462000000300003 · DOI · Paper page
- Ballard, 2020, Neurobiological research with suicidal participants: a framework for investigators, Gen. Hosp. Psychiatr., 62, 43, 10.1016/j.genhosppsych.2019.11.007 · DOI
- Berman, 2000, Antidepressant effects of ketamine in depressed patients, Biol. Psychiatr., 47, 351, 10.1016/S0006-3223(99)00230-9 · DOI · Paper page
- Bernstein, 1986, Development, reliability, and validity of a dissociation scale, J. Nerv. Ment. Dis., 174, 727, 10.1097/00005053-198612000-00004 · DOI · Paper page
- Carlson, 1993, An update on the dissociative experiences scale, Dissociation, 6, 16
- Castle, 2017, Effect of ketamine dose on self-rated dissociation in patients with treatment refractory anxiety disorders, J. Psychopharmacol., 31, 1306, 10.1177/0269881117725685 · DOI
- Černis, 2020, Dissociation in relation to other mental health conditions: an exploration using network analysis: dissociation across mental health, J. Psychiatr. Res., 136, 460, 10.1016/j.jpsychires.2020.08.023 · DOI
- Cooper, 2017, Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review, World J. Biol. Psychiatr., 18, 410, 10.3109/15622975.2016.1139747 · DOI · Paper page
- Correia-Melo, 2017, Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review, Neuropsychiatric Dis. Treat., 13, 1627, 10.2147/NDT.S135623 · DOI · Paper page
- Correia-Melo, 2018, Comparative study of esketamine and racemic ketamine in treatment-resistant depression: protocol for a non-inferiority clinical trial, Med. (United States), 97
- Correia-Melo, 2017, S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatment-resistant depression, Rev. Bras. Psiquiatr., 39, 188, 10.1590/1516-4446-2016-2070 · DOI
- Fekadu, 2009, A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method, J. Clin. Psychiatr., 70, 177, 10.4088/JCP.08m04309 · DOI · Paper page
- Fiszman, 2004, A adaptação transcultural para o português do instrumento dissociative experiences scale para rastrear e quantificar os fenômenos dissociativos, Rev. Bras. Psiquiatr., 26, 164, 10.1590/S1516-44462004000300006 · DOI
- Gómez-Pérez, 2013, Predictors of trait dissociation and peritraumatic dissociation induced via cold pressor, Psychiatr. Res., 210, 274, 10.1016/j.psychres.2013.06.001 · DOI
- Leonard, 1999, Dissociation in the laboratory: a comparison of strategies, Behav. Res. Ther., 37, 49, 10.1016/S0005-7967(98)00072-2 · DOI
- Lipsanen, 2004, Exploring the relations between depression, somatization, dissociation and alexithymia--overlapping or independent constructs?, Psychopathology, 37, 200, 10.1159/000080132 · DOI · Paper page
- Longden, 2020, The relationship between dissociation and symptoms of psychosis: a meta-analysis, Schizophr. Bull., 46, 1104, 10.1093/schbul/sbaa037 · DOI · Paper page
- Messer, 2010, Maintenance ketamine treatment produces long-term recovery from depression, Prim. Psychiatr., 17, 48
- Montgomery, 1979, A new depression scale designed to be sensitive to change, Br. J. Psychiatry, 134, 382, 10.1192/bjp.134.4.382 · DOI · Paper page
- Niciu, 2018, Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression, J. Affect. Disord., 232, 310, 10.1016/j.jad.2018.02.049 · DOI · Paper page
- Nunes, 2018, Efficacy of esketamine in the treatment of negative symptoms in schizophrenia - a case series, Schizophr. Res., 202, 394, 10.1016/j.schres.2018.06.034 · DOI
- Ozer, 2003, Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis, Psychol. Bull., 129, 52, 10.1037/0033-2909.129.1.52 · DOI · Paper page
- Pennybaker, 2017, Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion, J. Affect. Disord., 208, 560, 10.1016/j.jad.2016.10.026 · DOI · Paper page
- Petersen, 2005, Empirical testing of two models for staging antidepressant treatment resistance, J. Clin. Psychopharmacol., 25, 336, 10.1097/01.jcp.0000169036.40755.16 · DOI · Paper page
- Petrakis, 2004, Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism, Am. J. Psychiatr., 161, 1776, 10.1176/ajp.161.10.1776 · DOI · Paper page
- Poerio, 2016, Tracking potentiating states of dissociation: an intensive clinical case study of sleep, daydreaming, mood, and depersonalization/derealization, Front. Psychol., 7, 1231, 10.3389/fpsyg.2016.01231 · DOI
- Singh, 2016, Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study, Biol. Psychiatr., 80, 424, 10.1016/j.biopsych.2015.10.018 · DOI · Paper page
- Swainson, 2021, The Canadian network for mood and anxiety treatments (CANMAT) task force recommendations for the use of racemic ketamine in adults with major depressive disorder: recommandations du groupe de travail du réseau canadien pour les traitements de L’humeur et, Can. J. Psychiatr., 66, 113, 10.1177/0706743720970860 · DOI · Paper page
- van Heugten-Van der Kloet, 2015, MDMA, cannabis, and cocaine produce acute dissociative symptoms, Psychiatr. Res., 228, 907, 10.1016/j.psychres.2015.04.028 · DOI
- van Huijstee, 2018, The dissociative subtype of post-traumatic stress disorder: research update on clinical and neurobiological features, Curr. Top. Behav. Neurosci., 38, 229, 10.1007/7854_2017_33 · DOI
- Zarate, 2006, A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression, Arch. Gen. Psychiatr., 63, 856, 10.1001/archpsyc.63.8.856 · DOI · Paper page
- Zhang, 2014, R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine, Pharmacol. Biochem. Behav., 116, 137, 10.1016/j.pbb.2013.11.033 · DOI · Paper page
- Zoellner, 2007, Dissociation and serenity induction, J. Behav. Ther. Exp. Psychiatr., 38, 252, 10.1016/j.jbtep.2006.06.003 · DOI
Cited by
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis
Fountoulakis, K. N., Saitis, A., & Schatzberg, A. F. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240515 · Cited by 90
Hull, T. D., Malgaroli, M., Gazzaley, A., Akiki, T. J., Madan, A., Vando, L., Arden, K., Swain, J., Klotz, M., & Paleos, C. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.004 · Cited by 58
Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
Bandeira, I. D., Lins-Silva, D. H., Cavenaghi, V. B., Dorea-Bandeira, I., Faria-Guimarães, D., Barouh, J. L., Jesus-Nunes, A. P., Beanes, G., Souza, L. S., Leal, G. C., et al. (2022) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000330 · Cited by 39
Self-citationNeurobiological and genetic correlates of the dissociative subtype of posttraumatic stress disorder.
Wolf, E. J., Hawn, S. E., Sullivan, D. R., Miller, M. W., Sanborn, V., Brown, E., Neale, Z., Fein-Schaffer, D., Zhao, X., Logue, M. W., et al. (2023) · Journal of Psychopathology and Clinical Science · doi:10.1037/abn0000795 · Cited by 23
Naudet, F., Pellen, C., Fodor, L. A., Gastaldon, C., Barbui, C., Turner, E. H., Le Pabic, E., & Cristea, I. A. (2025) · BMC Medicine · doi:10.1186/s12916-025-04435-x · Cited by 6
Metadata
- Authors
- Mello, R. P., Echegaray, M. V. F., Jesus-Nunes, A. P., Leal, G. C., Magnavita, G. M., Vieira, F., Caliman-Fontes, A. T., Telles, M., Guerreiro-Costa, L. N. F., Souza-Marques, B., Bandeira, I. D., Santos-Lima, C., Marback, R. F., Correia-Melo, F. S., Lacerda, A. L. T., & Quarantini, L. C.
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 138
- Pages
- 576-583
- ISSN
- 0022-3956 (ISSN-L)
- OpenAlex
- W3162004623
- Cited by
- 21
- References
- 20
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial. https://app.cochat.ai/papers/10.1016/j.jpsychires.2021.05.014
- The paper
- Mello, R. P., Echegaray, M. V. F., Jesus-Nunes, A. P., Leal, G. C., Magnavita, G. M., Vieira, F., Caliman-Fontes, A. T., Telles, M., Guerreiro-Costa, L. N. F., Souza-Marques, B., Bandeira, I. D., Santos-Lima, C., Marback, R. F., Correia-Melo, F. S., Lacerda, A. L. T., & Quarantini, L. C. (2021). Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2021.05.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.